Last reviewed · How we verify
High dose WenXin keli
WenXin keli is a traditional Chinese medicine formulation that modulates cardiac electrophysiology and reduces arrhythmia susceptibility through multi-target effects on ion channels and cardiac tissue.
WenXin keli is a traditional Chinese medicine formulation that modulates cardiac electrophysiology and reduces arrhythmia susceptibility through multi-target effects on ion channels and cardiac tissue. Used for Atrial fibrillation, Premature ventricular contractions, Premature atrial contractions.
At a glance
| Generic name | High dose WenXin keli |
|---|---|
| Also known as | 2 times the amount of Wenxin keli |
| Sponsor | Beijing Bozhiyin T&S Co., Ltd. |
| Drug class | Traditional Chinese medicine / herbal formulation |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
WenXin keli (also known as Wenxin Keli or Wenxinkeli) is a proprietary Chinese herbal medicine containing multiple botanical components. It acts through multiple mechanisms including modulation of cardiac potassium and calcium channels, reduction of cardiac automaticity, and improvement of cardiac conduction properties. The formulation is used primarily for management of arrhythmias, particularly atrial fibrillation and premature beats.
Approved indications
- Atrial fibrillation
- Premature ventricular contractions
- Premature atrial contractions
- Cardiac arrhythmias
Common side effects
- Gastrointestinal upset
- Dizziness
- Palpitations
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- High dose WenXin keli CI brief — competitive landscape report
- High dose WenXin keli updates RSS · CI watch RSS
- Beijing Bozhiyin T&S Co., Ltd. portfolio CI